A Prospective Study to Compare a Symptom-Based Reflux Disease Questionnaire to 48-h Wireless pH Monitoring for the Identification of Gastroesophageal Reflux.

Slides:



Advertisements
Similar presentations
A 50-year-old man with a history of symptomatic gastroesophageal reflux disease (GERD) has Barrett’s esophagus diagnosed on upper endoscopy. Which of.
Advertisements

Nursing Care of Patients WithUpper GI Disturbances
Endoscopic Diagnosis of Hiatal Hernia Gilbert Simoni, MD Advanced Gastroenterology, Inc And Chief, division of gastroenterology Los Robles Hospital and.
Gastroesophageal Reflux in Infants and Children Melissa Velez.
GERD Brandon Hoff.
ESOPHAGEAL pH STUDIES IN ESOPHAGEAL DISEASE
WILLIAM J. SALYERS, JR., MD, MPH DIVISION CHIEF/MEDICAL DIRECTOR KU WICHITA GASTROENTEROLOGY ASSOCIATE PROGRAM DIRECTOR INTERNAL MEDICINE RESIDENCY Putting.
Figure 1. Higher prevalence of significant GER symptoms in patients with COPD. The prevalence of significant GER symptoms (heartburn and/or regurgitation.
1 Literature Review Peter R. McNally, DO, FACP, FACG Lone Tree, Colorado.
GastroEsophageal Reflux Disease (GERD)
GERD Jaspreet Kaur 1488 MD 4.
Gastroesophageal Reflux Disease (GERD)
Michelle Dotto April 3, 2003 Voice Disorders ASC 823C
Gastroesophageal Reflux Disease: Beyond Heartburn Annette Y. Kwon, M.D. Edward W. Holt, M.D. October 1, 2011.
Heartburn aka GERD, Gastric Reflux, Ulcers. Heartburn Americans spend $10 billion annually treating gastric reflux.
Gastroesophageal Reflux Disease (GERD)
Esophageal Problems after Gastric Banding
Case # 2 Mr. Rendly.  39 y/o w/m here for initial evaluation  CC: “heartburn symptoms after each meal” This started a year ago, mostly in response to.
Gastroesophageal Reflux Disease (GERD)
Results Recruitment 507 out of 4417 patients were eligible to take part in the study 131 of them (25.5%) participated in the study Demographics Male-female.
Edward Auyang, MD, MS, FACS Assistant Professor of Surgery
New Techniques and Perspectives Presented on: May 17th 2014
A gastroenterologist’s view of GERD and its pre-operative workup
Gastrointestinal Diseases Dr. Maha Arafah Pathology, 2012.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
SCREENING OF GASTROESOPHAGEAL REFLUX IN CHILDREN First author: Liana Stanciu Coordinator: Professor Doctor Oana Marginean Coauthors : Cosmin Oprea and.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question.
1 Esophageal Cancer. 2 Y One of the most lethal tumors Y Starts at the lining and spreads outward Y Squamous cell carcinoma Y Adenocarcinoma.
Gastroesophageal Reflux Disease PRESONTATION BY MELISSA VANDYKE.
GROUP D.  narrowing of the esophagus(distal) near the junction with the stomach (squamocolumnar jxn).  sequelae of gastroesophageal reflux– induced.
Gastro-oesophageal reflux disease is the term used to describe a histopathological alteration resulting from episodes of reflux of acid, pepsin and occasionally.
Gastroesophageal Reflux Disease (GERD). * Definition: inflammation of the lower part of the esophagus due to abnormal reflux of gastric contents into.
Digestive Disorders Esophageal Disorders.  Esophagus  The organ which moves food from the pharynx to the stomach  Moves food through the process of.
Rocco Maurizio Zagari, MD, Graham Richard Law, PhD, Lorenzo Fuccio, MD, Paolo Pozzato, MD, David Forman, Phd and Franco Bazzoli, MD.
The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.
Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors F Zerbib, A Duriez, S Roman, M.
Understanding Your Gastroesophageal Reflux Disease (GERD)
POTENTIAL PRECIPITATING FACTORS OF ESOPHAGEAL VARICEAL BLEEDING: A CASE – CONTROL STUDY F1 KIM EUN YEONG Wei-Chih Liao, MD, Ming-Chih Hou, MD, Chen-Jung.
Bob Etemad, MD Medical Director of Endoscopy Main Line Health System.
Judy Baker Petitto, N.P SMH Physicians Network
Minimally Invasive Techniques for GERD
Gastroesophageal Reflux Disease (GERD)
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus The Prague C & M Criteria Gastroenterology 2006;131:1392~1399 This.
The Prevalence of and Risk Factors for Barrett Esophagus in a Korean Population - A Nationwide Multicenter Prospective Study - J Clin Gastroenterol 2009.
Baby with vomiting, when to worry
Gastro-Esophageal Reflux Disease.
D. Kiagiadaki, V. Bachy, M. Remacle, S. Van Der Vorst, G. Lawson
Volume 119, Issue 4, Pages (April 2001)
Gastroesophageal reflux disease
Gastroesophageal Reflux in Infants and Children Melissa Velez.
Contribution by: Prof. Dr. J.J. Kolkman
Digestive Disorders Esophageal Disorders.
Clinical algorithm for the diagnosis of chronic cough.
Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux  Robert A. Ganz, Steven A. Edmundowicz,
Figure 3 Algorithm from working group describing
Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease  Evan S. Dellon, Nicholas J. Shaheen 
INFECTIOUS ESOPHAGITIS
Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease  Evan S. Dellon, Nicholas J. Shaheen 
Care of Patients with Esophageal Problems
William K. Fackler, Tina M. Ours, Michael F. Vaezi, Joel E. Richter 
RESPIRATORY SERVICES E-Consultation Top Tips
Acid Reflux Zillia Biniam , 5th hour.
Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease  Chandra Prakash, Ray E. Clouse  Clinical Gastroenterology.
Volume 156, Issue 5, Pages (April 2019)
Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy Joel E. Richter, M.D. Gastroenterology & Hepatology.
Francine M. Ducharme, MD, Megan E. Jensen, PhD, Morton J
GASTROESOPHAGEAL REFLUX

Foregut function before and after lung transplant
Presentation transcript:

A Prospective Study to Compare a Symptom-Based Reflux Disease Questionnaire to 48-h Wireless pH Monitoring for the Identification of Gastroesophageal Reflux Brian E. Lacy, PhD, MD, FACG, Robert Chehade, MD 1 and Michael D. Crowell, PhD, FACG The American Journal of GASTROENTEROLOGY VOLUME 106 : R1 Lee Tae-In / Prof. Cho Joon-Hyung

 Gastroesophageal reflux disease (GERD) The most common out-patient gastroenterology diagnosis in the United States Controversy exists over how best to diagnose GERD  The gastroesophageal reflux disease questionnaire (GerdQ) Validated questionnaire that identifies patients with GERD  The aim of this study INTRODUCTION To assess GerdQ scores in relationship to 48-h wireless pH monitoring To determine the performance of the GerdQ in patients studied on/off acid suppression

 Inclusion criteria 18 years of age or older with symptoms thought secondary to GERD for 48-h wireless pH capsule testing 1 October 2008 ~ 31 October 2009  Exclusion criteria Dominant symptom of patients was chest pain, chronic cough, asthma, or ENT symptoms (e.g., hoarseness, globus, sore throat, post-nasal drip) Known or suspected esophageal varices, a cardiac defibrillator or other device inserted state  Asked to stop the medication during 7 days in advance of the pH study if on PPI 5 days in advance of the pH study if on anti-histamine METHODS Patients

 The two standardized methods for the deployment of the wireless pH capsule Endoscopic placement or trans-orally guided by manometric criteria  Asked to keep a diary Symptoms and activity, including body position(supine vs upright) during the 48-h recording period  Symptom association probability(SAP) scores were calculated at the 95% level for symptoms of heartburn and regurgitation  Premature detachment of the capsule an abrupt drop and rise in pH (pH 7.0) METHODS Wireless pH capsule placement

For the next 6 questions please think about your symptoms over the past 7 days… A. 1. How often did you have a burning feeling behind your breastbone (heartburn)? 1. 0 days 2. 1 day days days 2. How often did you have stomach contents (liquid or food) moving upwards to your throat or mouth (regurgitation)? 1. 0 days 2. 1 day days days B. 1. How often did you have pain in the center of the upper stomach? 1. 0 days 2. 1 day days days 2. How often did you have nausea? 1. 0 days 2. 1 day days days C. 1. How often did you have difficulty getting a good night’s sleep because of your heartburn and/or regurgitation? 1. 0 days 2. 1 day days days 2. How often did you take additional medications for your heartburn and/or regurgitation other than what your physician t old you to take? 1. 0 days 2. 1 day days days METHODS Questionnaires Supplementary appendix addendum

RESULTS

RESULTS Demographics

RESULTS Wireless pH capsule placement EndoscopicOrally Wireless pH capsule placement 202 patients (56%)156 patients (44%)  Premature detachment or loss of signal resulted in the exclusion of six studies (1.7%)

 The 48-h wireless pH study either off(n=178) or on(n=180) acid suppression  Patients studied on acid suppression 48%(daily qd PPI), 49%(daily bid PPI), 3%(anti-histamine or combination)  The odds of an abnormal study were 5.04(95% CI, ) times greater in patients studied off PPI compared with patients studied on PPI OR : 4.09 (95% CI, ; P <0.001) on daily PPI OR : 6.08 (95% CI, 3.29 – ; P < 0.001) on twice-daily PPI  The odds of the SAP being >95% was 5.69 (95% CI, 3.36 – 9.64 ; P < 0.001) for patients studied off PPI compared with on PPI RESULTS pH recordings and SAP

EsophagitisBx-proven Barrett’s esophagus Hiatal herniaEsophageal stricture (non-occluding) 17%12%69%3% RESULTS Endoscopic findings  Upper endoscopy findings were not significantly related to whether or not the patient was on PPI(n=86; 70%) or off PPI (n=73; 64%; OR 1.31; 95% CI, ; P=0.34)

RESULTS GerdQ scores

 Each of six individual GerdQ questions was analyzed separately  Only the GerdQ subscale for regurgitation was positively associated with an abnormal pH study (OR, 1.43; 95% CI, 1.01 – 2.03) RESULTS GerdQ scores

 Elevated GerdQ scores were associated with increased likelihood of an abnormal 48-h pH study  GerdQ subscale scores for regurgitation were associated with an abnormal wireless pH study  The GerdQ performed more robustly for patients studied off acid suppressants  Overall, the GerdQ cannot accurately diagnose acid reflux when compared with 48-h wireless pH testing CONCLUSION